Date Range
toReport Types
Condition
See all (5)
Region of the Body
See all (9)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Rivaroxaban is an adequate treatment for thromboprophylaxis after total knee arthroplasty
Lancet. 2009 May 16;373(9676):1673-80. Epub 2009 May 4
Extended thromboprophylaxis beneficial after total knee arthroplasty
Thromb Res. 2010 Oct;126(4):e298-304
Thromboprophylaxis with enoxaparin for 20 days postdischarge reduced incidence of DVT
Arthroscopy. 2007 Jul;23(7):696-702
Prolonged use of Dalteparin for thromboprophylaxis not effective in reducing DVT incidence
Acta Orthop. 2007 Aug;78(4):528-35
Nadroparin or fondaparinux for thromboprophylaxis after ankle/foot fracture managed conservatively
Injury. 2017 Apr;48(4):936-940
The routine use of potent anti-coagulants following TJR is unnecessary
J Bone Joint Surg Br. 2012 Jan;94(1):113-21
Thromboprophylaxis with rivaroxaban versus enoxaparin in total knee and hip arthroplasty
Sci Rep. 2016 Mar 29;6:23726
Rivaroxaban offers effective extended thromboprophylaxis than enoxaparin after THA
Lancet. 2008 Jul 5;372(9632):31-9. Epub 2008 Jun 24
Routine thromboprophylaxis appears unnecessary following knee arthroscopy and lower-leg casting
N Engl J Med. 2017 Feb 9;376(6):515-525.
Routine thromboprophylaxis with anticoagulants unnecessary following nonmajor knee arthroscopy
J Thromb Thrombolysis. 2018 May;45(4):562-570
Routine thromboprophylaxis not necessary in treatment of patients with foot/ankle fracture
Foot Ankle Int. 2016 Nov;37(11):1218-1224
Edoxaban has similar efficacy to enoxaparin for thromboprophylaxis after THA
J Arthroplasty. 2014 Dec;29(12):2439-46.
Is chemical thromboprophylaxis necessary following total hip replacement?
J Bone Joint Surg Br. 2011 Feb;93(2):251-6
THA: No difference in blood loss between pre/postoperative start of thromboprophylaxis
Clin Orthop Relat Res. 2012 Sep;470(9):2591-8. doi: 10.1007/s11999-012-2320-9. Epub 2012 Apr 3.
Extended thromboprophylaxis with aspirin noninferior to dalteparin for THA patients
Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004